Cytek Biosciences (CTKB) Payables (2020 - 2026)
Cytek Biosciences (CTKB) posted Payables of $6.7 million for Q1 2026, up 5.16% on a QoQ basis from $6.4 million in Q4 2025, and up 7.91% year-over-year from $6.2 million in Q1 2025.
Cytek Biosciences (CTKB) Payables (2020 - 2026) Analysis & Trends
Cytek Biosciences' Payables history runs 7 years deep, the most recent figure standing at $6.7 million for Q1 2026.
- Quarterly Payables rose 7.91% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 7.91% YoY) and the FY2025 annual result came in at $6.4 million, up 15.93% from the prior year.
- Payables was $6.7 million for Q1 2026 at Cytek Biosciences, up from $6.4 million in the prior quarter.
- Across five years, Payables topped out at $7.6 million in Q3 2025 and bottomed at $3.0 million in Q4 2023.
- A 5-year average of $5.4 million and a median of $5.5 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables slumped 54.33% — and 2025, when it soared 114.76%.
- Cytek Biosciences' Payables stood at $4.8 million in 2022, then sank by 36.9% to $3.0 million in 2023, then jumped by 82.35% to $5.5 million in 2024, then rose by 15.93% to $6.4 million in 2025, then increased by 5.16% to $6.7 million in 2026.
- Business Quant data shows CTKB's Payables at $6.7 million in Q1 2026, $6.4 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 5.78 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.93 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.39 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.42 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | 6.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.41 Mn |
| Sep 30, 2025 | 7.63 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 6.25 Mn |
| Dec 31, 2024 | 5.53 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 5.97 Mn |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 3.32 Mn |